LUNAR1 and colorectal carcinoma: Being correlated with poorer CRC patients' clinical features, SNHG3 and LUNAR1 lncRNAs might constitute potential putative therapeutic targets for CRC, per identified downstream genes or proteins in silico, a step toward ncRNA-based precision medicine.